Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from in-PharmaTechnologis

22:45 EDT 22nd September 2018 | BioPortfolio

Here are the most relevant search results for "in-PharmaTechnologis" found in our extensive news archives from over 250 global news sources.

More Information about in-PharmaTechnologis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about in-PharmaTechnologis for you to read. Along with our medical data and news we also list in-PharmaTechnologis Clinical Trials, which are updated daily. BioPortfolio also has a large database of in-PharmaTechnologis Companies for you to search.

Showing News Articles 1–25 of 398 from in-PharmaTechnologis

Friday 21st September 2018

FDA extends the scope of opioid REMS to include IR and education

The FDA has approved an updated opioid analgesics risk evaluation and mitigation strategy, including measures that apply to immediate-release opioids.

Siga signs $629m contract with BARDA for smallpox drug stockpiling

Siga signed a multiyear contract with BARDA for the delivery of oral and IV formulations of TPOXX to the Strategic National Stockpile.

Infographic: Breaking down antimicrobial resistance

The topic of antimicrobial resistance is back in the spotlight after the US FDA released a new website and a number of proposals to encourage the drug development in the area.

Switzerland to Canada: GSK transfers Voltaren tech for local supply

GSK has invested $27.8m into manufacturing operations in Canada, including a technology transfer of Voltaren products from facilities in Switzerland to Mississauga.

Thursday 20th September 2018

Strides hamstrung by US FDA Form 483

Strides announced that a US FDA inspection of its Bangalore facility has resulted in a Form 483, noting three observations.

Allergan and Sosei suspend development on Alzheimer’s drug

Sosei has voluntarily suspended development on its Alzheimerâs drug, co-licensed with Allergan, after toxicological effects were reported.

Aucta and Catalent enter commercial supply agreement

Aucta and Catalent entered a commercial supply agreement for vigabatrin to employ Catalentâs dosage new drug packaging technology.

Wednesday 19th September 2018

‘Unmerited’ hep C patent contributes to Gilead monopoly, says NGO

The European Patent Office has upheld protection relating to Gileadâs costly Hepatitis C drug Sovaldi, which MÃdecins du Monde claims prevents patients from receiving affordable treatment.

Takeda to move US base to Boston

Takeda will become the latest company to base its operations within Massachusetts, after announcing it would leave its Deerfield, Illinois headquarters.

Monday 17th September 2018

‘Revamped’ MannKind secures $105m licensing deal, plans Afrezza expansion

MannKind Corporation, of Afrezza fame, and United Therapeutics have signed an exclusive licensing and collaboration agreement for dry powder pulmonary hypertension products.

US FDA ups the ante against antimicrobial resistance

The US FDA announced a number of measures it considers as a viable means of combatting AMR, including the idea of hospitals paying a âsubscriptionâ to access new medicines.

Looking to the future of a safe supply chain

in-PharmaTechnologist (IPT) speaks to Ettore Cucchetti (EC), CEO of ACGI, about how the biopharma industry is adapting to the threat of counterfeit medicine and how he expects the industry will adopt further measures beyond those stipulated in the EU FMD.

Friday 14th September 2018

Five stories that speak volumes about US generics market

As Novartis looks to sell a major chunk of its generics portfolio in the US, in-PharmaTechnologist has a look back at some of the stories this year that have signposted larger, on-going trends in the US generics market.

Thursday 13th September 2018

Otsuka to facilitate patient access to connected care system Abilify Mycite

Otsuka collaborates with Magellan Health to bring the Abilify Mycite system to patients, and further clinicians insights on the connected care system.

Novo Nordisk becomes latest to stockpile drugs ahead of Brexit

Novo Nordisk joins a growing list of pharma companies that have announced plans to build a stockpile prior to the Brexit deadline.

Pfizer, Merck and Novartis to shut manufacturing sites as hurricane looms

Major pharmaceutical companies and CMOs in the US have announced emergency contingency plans, including facility closures and the relocation of drug products, as Hurricane Florence approaches southeastern shores.

Pfizer, Merck and Novartis to shut manufacturing sites as Hurricane Florence looms

Major pharmaceutical companies and CMOs in the US have announced emergency contingency plans, including facility closures and the relocation of drug products, as Hurricane Florence approaches southeastern shores.

Wednesday 12th September 2018

Chinese API producer refuses entry of EU inspectors

Jiangsu Yew Pharmaceutical outright refused permission for inspectors from Hungary to visit its site, resulting in the suspension of the companyâs marketing authorisation.

UK seizes unlicensed meds ‘home-made’ in cement mixer

Three family members charged with producing and supplying unlicensed medicines in the UK used pressing equipment and dyes imported from China, says MHRA.

Tuesday 11th September 2018

Novartis announces Alcon move to Switzerland ahead of spin-out

Ahead of a spin-out, Alcon has announced it will relocate its global headquarters to Switzerland.

Microbubble technology bypasses blood brain barrier, says researcher

A study at Washington University in St. Louis has shown a new way to deliver drugs to the brainstem in a non-invasive administration: microbubbles and ultrasound.

Monday 10th September 2018

UK gov’t guidance leaving too little time to adjust to ‘no deal’ Brexit?

IPT speaks to life sciences lawyer, Jane Summerfield, to interpret the recent guidance from the UK government in the event of a âno dealâ Brexit.

Novartis sheds oral solid generics in $900m Aurobindo deal

In Novartisâ latest restructuring move for 2018, the pharma giant announced plans to sell US generic oral solids and dermatology businesses to Aurobindo Pharma US.

Friday 7th September 2018

Hired and Retired: Summer Edition

Thursday 6th September 2018

Lonza stresses ‘flexibility’ advantages on launch of Capsugel Colorista

Lonza launched its Capsugel Colorista product, which means it can now produce capsules in 150 colour options.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks